Trial Profile
A prospective, cohort study of tenofovir-disoproxil-fumarate and entecavir in patients with chronic hepatitis-B virus infection.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Nov 2016
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 14 Nov 2016 New trial record
- 04 Oct 2016 Results published in the American Journal of Therapeutics